A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 12-WEEK STUDY TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF ORAL DIFELIKEFALIN IN SUBJECTS WITH ADVANCED CHRONIC KIDNEY DISEASE AND MODERATE-TO-SEVERE PRURITUS WITH A 24-WEEK OPEN-LABEL EXTENSION
- Registry ID
- CR845-110210
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- CARA THERAPEUTICS
- Start date
- 2024-01-09
- Completion date
- 2024-02-23
- Last update
- 2023-09-13
Conditions
Related clinical trials
- AN EXPLORATORY PROOF OF CONCEPT STUDY TO ASSESS THE PHARMACOKINETICS/PHARMACODYNAMICS OF NEMOLIZUMAB (CD14152) IN ADULT PARTICIPANTS WITH CHRONIC PRURITUS OF UNKNOWN ORIGIN (CPUO)
- PODOMOUNT-BASKET, A PHASE II, MULTICENTRE, RANDOMISED, 2-ARM PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED BASKET TRIAL TO ASSESS SAFETY, TOLERABILITY, PK, AND EFFICACY OF BI 764198 IN FOUR PROTEINURIC KIDNEY DISEASES
- A PHASE 2A, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VX-407 IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WHO HAVE A SUBSET OF PKD1 GENE VARIANTS
- A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO
INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB FOR THE TREATMENT OF PRURITUS OF
LICHEN SIMPLEX CHRONICUS (LSC) IN ADULTS
- BLEEDING REDUCTION IN ACUTE AND CHRONIC KIDNEY PATIENTS HAVING SURGERY
(BRACKETS) PILOT TRIAL
- A PHASE IIB, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, DOSE-FINDING STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BALCINRENONE IN COMBINATION WITH DAPAGLIFLOZIN COMPARED WITH DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA
View on source registry